Georgia Capital PLC Financial and Operational Report
DELEVERAGING ACROSS OUR PRIVATE PORTFOLIO
AGGREGATED LEVERAGE
ACROSS OUR PRIVATE LARGE
AND INVESTMENT STAGE
PORTFOLIO COMPANIES AT
3.1x AS OF 30-SEP-23
ADJUSTED NET DEBT/EBITDA
30-JUN-23
CHANGE
30-SEP-23
GEORGIA
CAPITAL
TARGET
(OVER THE CYCLE)
LARGE PORTFOLIO COMPANIES
Retail (pharmacy)¹
1.7x
+0.6x
2.3x
Up to 1.5x
Hospitals
4.1x
+0.2x
4.3x
Up to 2.5x
Insurance (P&C and Medical)
No leverage
NMF
No leverage
No leverage
INVESTMENT STAGE PORTFOLIO COMPANIES
Renewable Energy²
7.1x
-0.1x
7.0x
Up to 6.0x
Education
1.0x
+0.3x
1.3x
Up to 2.5x
Clinics and Diagnostics
7.1x
-2.4x
4.7x3
Up to 2.5x
Georgia Capital PLC | General note: Figures for Hospitals, Retail (Pharmacy), Clinics and Diagnostics are given excluding IFRS 16 effects; Net debt/EBITDA is adjusted for capital commitments. 1. Includes the application of the minority
buyout agreement. 2. Renewable energy ratio is calculated in US$. 3. LTM EBITDA excludes the gain of GEL 2.9 million from the sale of one of the polyclinics buildings in 3Q23. The net debt includes the receivable of US$ 6.2 million
incurred from the sales transaction.
18View entire presentation